Surgical transcarotid artery revascularisation (TCAR) demonstrated significantly lower stroke risk compared to percutaneous transfemoral carotid artery stenting (TF-CAS) over a 3-year follow-up period, according to a comprehensive comparative effectiveness study published in JAMA Network Open, offering critical guidance for physicians and patients selecting carotid stenting procedures.
Baxter International Inc. has announced the European launch of its Hemopatch Sealing Hemostat with room temperature storage capability, eliminating the need for refrigeration and enabling immediate accessibility in operating theatres.
Scientists have developed an innovative low-cost laparoscope that could dramatically increase access to minimally invasive surgery in developing nations. The device, called KeyScope, delivers comparable imaging performance to standard hospital systems but costs just $1,000 compared to over $130,000 for conventional equipment.
Robotic surgery pioneer Intuitive Surgical is set to strengthen its European presence through the acquisition of key distribution businesses across Southern Europe, marking a significant development in the medical technology sector’s regional consolidation.
Phase II trial demonstrates superior outcomes compared to synthetic grafts in both civilian and military settings, with significantly lower amputation rates and infection risks.
A new study projects significant reductions in postoperative complications and substantial cost savings through the implementation of a system-wide preoperative nutrition programme.
In an historic achievement, Dr. Feras Khaliel and his team at King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh, Saudi Arabia, successfully performed the world’s first fully robotic heart transplant on a 16-year-old patient with end-stage heart failure. This innovative procedure reduced recovery times and surgical risks, setting a new standard for cardiac […]
The American Heart Association and American College of Cardiology have jointly published an updated guideline for managing cardiovascular risks in patients undergoing noncardiac surgery, reflecting a decade of new evidence since the last update in 2014.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.